https://cureos-dev.dwsstaging.net.au/news-views/ 2023-06-20T09:45:39+00:00 https://cureos-dev.dwsstaging.net.au/kriya-therapeutics-presents-preclinical-data-for-kriya-825-gene-therapy-in-geographic-atrophy/ 2026-08-24T05:59:23+00:00 https://cureos-dev.dwsstaging.net.au/wp-content/uploads/2025/06/ophthalmology-graphic-02-1-768x403-1.jpg https://cureos-dev.dwsstaging.net.au/new-approved-treatments-for-geographic-atrophy-insights/ 2026-05-11T22:50:02+00:00 https://cureos-dev.dwsstaging.net.au/exciting-news-the-6-month-interim-analysis-of-the-furgghorn-study-now-published-in-apjo/ 2026-05-11T22:46:54+00:00 https://cureos-dev.dwsstaging.net.au/high-dose-eylea-8mg-approved-in-china-for-wet-age-related-macular-degeneration/ 2025-06-02T23:24:06+00:00 https://cureos-dev.dwsstaging.net.au/evolving-therapies-for-geographic-atrophy/ 2025-05-29T22:22:12+00:00 https://cureos-dev.dwsstaging.net.au/exploring-geographic-atrophy-managing-patients-and-progress-in-treatments/ 2025-05-29T22:18:35+00:00 https://cureos-dev.dwsstaging.net.au/wp-content/uploads/2025/05/Figure-1-750x444-1.jpg https://cureos-dev.dwsstaging.net.au/the-furgghorn-study/ 2023-06-22T04:50:24+00:00 https://cureos-dev.dwsstaging.net.au/march-april-special-edition/ 2023-06-22T04:49:44+00:00